12例非结核分枝杆菌性脊柱炎手术治疗患者临床特征及治疗转归

目的:分析非结核分枝杆菌(non-tuberculous mycobacterial,NTM)性脊柱炎手术治疗患者临床特征,以提高临床诊治水平。方法:采用回顾性研究方法,参照入组标准收集并分析2023年1月至2024年9月首都医科大学附属北京胸科医院、青海省第四人民医院、哈尔滨医科大学附属哈尔滨市胸科医院骨科收治的12例经手术治疗的NTM性脊柱炎患者临床资料,包括患者人口学特征、临床症状及体征、病变部位、入院前诊断及治疗、入院后实验室检查、影像学检查、药物治疗方案、手术治疗方式及预后和随访情况。结果:12例NTM性脊柱炎患者均有1种或多种基础疾病或致免疫力低下的疾病;从发病到确诊的病程范围为12~24个月,其中,外院行抗结核治疗1年及以上者8例、6~9个月者4例。3例患者行MGIT 960液体培养,仅1例患者后续行TB-DNA检测;5例患者行NGS检测;2例患者行病理DNA诊断;2例患者行NGS+病理DNA定性。最终菌种鉴定到8种NTM,以鸟分枝杆菌复合群、胞内分枝杆菌和脓肿分枝杆菌复合群为主。术前抗NTM治疗6周者7例,8周者4例,仅1例合并肺部感染者治疗4周。4例首次手术患者,其中3例行单纯后路手术、1例因骨质破坏严重行单纯前路手术;8例再次手术患者,其中5例行前后路联合手术、1例行单纯前路手术、2例行窦道切除术,但有3例术后行3期手术或单纯窦道切除术。术后继续术前抗NTM方案治疗及康复训练8~12个月,随访2年后8例痊愈、4例有窦道或残腔(其中1例经7次手术后放弃治疗)。结论:NTM性脊柱炎多有明确职业接触史,感染菌种丰富,多因缺乏菌种鉴定而导致长期误诊误治,病程迁延,病理和分子生物学检测可明确诊断。手术治疗是病程迁延、脊柱损害严重患者的主要治疗手段,治愈率约为70%,再手术风险高,故应术前明确致病菌、精准诊断,并及时进行足量且有针对性的抗NTM治疗,以降低患者术后发生窦道及脓肿加重的风险,保证术后良好结局。

数字经济驱动扬州先进制造业与现代服务业融合的路径研究

在先进制造业与现代服务业融合的过程中,数字经济贯穿其中。文章阐述了数字经济对“两业”融合的作用,并在目前扬州“两业”融合基础之上,总结了扬州“两业”融合中的问题,提出了数字经济促进扬州“两业”融合的路径。

新型超声快速处理活检标本保存不同年限对DNA质量的影响

背景:新型超声组织处理技术越来越多地被用来进行分子生物学分析,研究新型超声处理不同存储年限组织DNA的质量,对进一步分子检测的标本质控具有重要意义。目的:探讨新型超声处理活检标本存储不同年限对DNA质量的影响,以期为分子检测探索最佳的标本存储时间。方法:收集40例乳腺穿刺小活检组织,采用超声技术制作石蜡标本,按照存储年限分为4组:<1年组、1-3年组、>3-5年组及>5年组,每组10例,对石蜡标本进行切片,每张切片厚3μm,切片10-15张,提取DNA后通过Nanophotometer N60超微量分光光度计和Qubit 4.0荧光计检测DNA的质量浓度,记录A_(260)/A_(280)比值判定DNA的纯度,利用全自动毛细管电泳核酸分析仪(Qsep 100)检测DNA片段完整性,以评估DNA片段的质量。结果与结论:4组样本A_(260)/A_(280)均值在1.8-2.0之间,达到纯度要求,无明显差异。4组样本的DNA质量浓度(Qubit浓度)均值分别为30.39,14.33,2.52,1.95 ng/μL;DNA的平均N/Q比值分别为6.48,14.18,24.56,29.86;DNA质量数均值分别为5.64,1.76,1.24,0.80;大片段占比均值分别为56.08%,17.72%,12.68%,7.90%。PCR检测内控基因Ct均值分别为15.32,17.09,18.39,21.24。与<1年组相比,其余3组DNA浓度显著降低,N/Q比值显著增加,DNA质量数和大片段占比均值显著降低,Ct值升高,差异有显著性意义(P<0.05)。实验结果表明,对于新型超声处理活检标本,应优先选择存储<1年的样本进行日常分子检测,储存3年内的样本可满足二代测序等检测要求,5年内样本仅可尝试进行PCR等检测,存储超过5年的样本不建议进行后续分子检测。

视觉评分系统分析透明矫治器和固定矫治器对牙齿光滑面的影响

背景:白斑病变是传统正畸治疗中常见的不良反应。目前有关透光透明矫治器和固定正畸矫治器对正畸治疗患者牙周健康状况、白斑病变发生率、唾液及相关细菌的影响差异仍存在一些争议。目的:采用视觉评分系统对比透明矫治器和固定矫治器对正畸牙齿光滑面的影响。方法:选择2018年1月至2022年12月河北医科大学第二医院口腔正畸科收治的患者80例,采用随机数字表法随机分为对照组(n=40)与观察组(n=40),对照组接受固定矫治器正畸治疗,观察组接受透明矫治器接正畸治疗。治疗前及治疗6,12,24个月后,每位患者选取13、33、16、36牙唇侧或颊侧作为研究对象,采用视觉评分系统评估白斑病变。结果与结论:①治疗前及治疗6,12,24个月后,两组患者牙齿白斑颜色与龋坏严重程度比较差异均无显著性意义(P>0.05);②对于13牙,治疗12个月后的白斑颜色级别与龋坏严重程度均高于治疗前(P<0.05);对于33牙,治疗12个月后的白斑颜色级别与龋坏严重程度均高于治疗前(P<0.05),治疗12个月后的龋坏严重程度高于治疗6个月后(P<0.05);对于16牙,治疗12个月后的白斑颜色级别与龋坏严重程度均高于治疗6个月后(P<0.05);③多水平有序多分类Logistic回归模型分析显示,不同牙位的白斑颜色、严重程度变化与矫治器类型相关性较小,受矫治时间因素影响较大,其中33、13牙初始白斑颜色变化和严重程度在治疗第12,24个月比较有统计学意义;④研究结果尚不能说明固定矫治器和透明矫治器对牙齿光滑面白斑病变的影响有所差异,但可以发现随着正畸治疗时间的延长,牙齿龋坏的风险有所增加。

基于热处理工艺的拖拉机发动机铝合金组织性能研究

采用不同时长的热处理工艺,对拖拉机发动机铝合金组织性能进行了对比分析。结果表明:热处理后,铝合金性能得到了较大程度的提高,若优先考虑材料性能,则应该采用180℃×4 h的单级热处理时效;若优先考虑工艺效率和成本,则可以采用150℃×1 h+170℃×1 h的双级热处理时效。

黄韧带骨化研究热点及趋势的可视化分析

背景:既往认为黄韧带骨化在人群中罕见发生,随着研究深入,发现其发病率逐渐上升,这引起大量学者的研究兴趣。目的:通过检索科学引文索引数据库核心集自1999年以来的有关黄韧带骨化的研究成果,使用文献计量学方法对数据进行可视化分析,回顾黄韧带骨化的研究历史,指示重要文献,梳理研究热点,为学者寻找研究方向提供思路。方法:以Web of Science核心集数据库为主,搜索并筛选黄韧带骨化相关论文,使用VOSviewer 1.6.19和CiteSpace 6.2.R6软件对年度发文量、研究国家、机构、被引文献、期刊、作者和关键词等进行可视化分析。结果与结论:①共纳入347篇文献,自1999年发文量呈螺旋上升,中国研究较日本起步晚,但是发文量后来居上,北京大学是发文量最多的机构,北京大学的陈仲强教授是发文量最多的学者。②被引用最多的10篇文献中5篇都与黄韧带骨化的手术治疗有关。③去除与研究主题直接相关的关键词,综合词频和中介中心性的结果发现,“胸椎脊髓病”“硬膜骨化”“微创手术”“后纵韧带骨化”处于领域研究的核心地位。④关键词聚类分析显示,黄韧带骨化的临床表现和手术治疗在疾病的研究中占比较大。⑤关键词时间线图及关键词突现分析显示,“微创手术”作为关键词出现在2015年前后,是突现强度最高的关键词,也是突现开始时间最晚的关键词,2019年开始受到学者广泛关注,关键词“硬膜骨化”的突现尚未结束。⑥黄韧带骨化的手术治疗一直处于研究前沿,微创手术方式的开发和研究、黄韧带骨化继发硬膜骨化的研究是该领域的研究热点。

维生素D治疗全面性发育迟缓患儿的临床疗效研究

背景 除了某些有明确病因的代谢性疾病导致的全面性发育迟缓(GDD),康复治疗是GDD的主要治疗方式;维生素D通过影响神经营养因子在调节神经细胞的发育和分化方面发挥着重要的神经保护作用;但目前关于补充维生素D对GDD患儿临床疗效的研究开展较少。目的 探讨补充不同剂量的维生素D对GDD患儿康复治疗的临床效果。方法 于2020年9月—2022年6月选取在郑州大学第三附属医院康复医学科首次住院就诊的120例GDD患儿为研究对象,采用随机区组化的方法将其分为常规组(38例)、400 U组(37例)和1 200 U组(35例)。常规组仅进行常规康复治疗;400 U组在常规康复治疗的基础上给予口服400 U/d维生素D;1 200 U组在常规康复训练的基础上给予口服1 200 U/d维生素D。收集3组患儿的性别、就诊年龄等基本资料;于入院时(治疗前)及第3个疗程末(治疗后)行血清25羟维生素D[25(OH)D]水平检测和Gesell发育量表评估[评估适应能力、大运动能力、精细运动能力、语言能力和社交能力5个能区的发育商(DQ)];记录发生在患儿住院期间不良事件的次数,并对上述资料进行分析比较。结果 3组患儿性别、居住地、出生季节、分娩方式、就诊年龄、出生体质量、出生胎龄、主要就诊原因比较,差异均无统计学意义(P>0.05)。治疗前,3组患儿25(OH)D水平、Gesell量表各能区DQ值比较,差异均无统计学意义(P>0.05);治疗后,1 200 U组患儿血25(OH)D水平、Gesell量表大运动能力、精细运动能力、语言能力DQ值高于常规组(P<0.05)。第1、2疗程期间,3组患儿不良事件发生率比较,差异无统计学意义(P>0.05);第3疗程期间,1 200 U组患儿不良事件发生率低于常规组及400 U组(P<0.05)。结论 补充1 200 U维生素D对GDD患儿的康复疗效有益,且能减少康复期间不良事件的发生率。

不同细胞来源外泌体miRNAs在胃癌进展及诊断和预后中的作用

背景:肿瘤微环境可通过多种途径参与胃癌的发生发展并促进胃癌化疗耐药,其中外泌体miRNAs介导的肿瘤微环境串话可诱导基质重编程,参与肿瘤异质性,并形成有利于肿瘤增殖、迁移、侵袭、免疫逃逸和化疗耐药的微环境。目的:对近年来外泌体miRNAs在胃癌微环境中的作用机制及其在胃癌诊断及预后评估中的应用进展作一综述。方法:以“Exosomal miRNAs,gastric cancer,angiogenesis,apoptosis,proliferation,migration,autophagy,invasion,immune response,chemotherapy resistance,biomarker”为英文检索词和“外泌体miRNAs,胃癌”为中文检索词分别检索PubMed及中国知网数据库。检索时限为2017-2024年。通过阅读文题及摘要进行初步筛选,排除研究内容相关性差及内容重复的文献,最终纳入77篇文献进行归纳探讨。结果与结论:①外泌体作为细胞间信息交流的重要载体,可携带miRNA等多种信息物质,通过激活靶细胞上的细胞表面受体、与受体细胞质膜融合及内吞作用3种途径实现细胞间信号传递。②外泌体miRNAs通过调节胃癌细胞增殖、凋亡、自噬、血管形成、侵袭转移、免疫应答以及耐药性的形成等多种途径,进而在胃癌进展中发挥着重要作用。③miRNA与靶mRNA相互作用及其调控网络广泛存在于肿瘤发生和人类癌症发展中,不同类型外泌体miRNAs对调控胃癌细胞凋亡具有不同的作用,鉴别不同外泌体miRNAs对胃癌细胞凋亡相关蛋白及通路的影响,合理运用其诱导剂或抑制剂可对胃癌细胞凋亡水平进行调控。④不同细胞来源的外泌体miRNAs通过将M1极化型巨噬细胞诱导为M2型,在肿瘤微环境的建立、血管生成、免疫应答及化疗耐药中扮演重要角色。⑤外泌体miRNAs广泛稳定存在于血液及其他体液中,其在胃癌患者中的差异性表达可作为胃癌患者诊断、预后及治疗依据。目前作为生物标志物研究较多的外泌体miRNAs包括miR-379-5p,miR-590-5p,miR-29s和miR-21等,其中miR-590-5p灵敏度与特异性分别为63.7%和86%,其表达水平与胃癌患者总体生存率、浸润深度密切相关。⑥设计外泌体miRNAs模拟物或抑制物,并利用纳米递送载体(如外泌体、脂质体)将其靶向递送至肿瘤部位以恢复miRNAs正常水平,可能是治疗胃癌的一种新策略。⑦虽然外泌体miRNAs在胃癌患者诊疗中具有很大的应用前景,但仍存在一些问题亟待解决,例如外泌体miRNAs的潜在靶点及作用机制尚未完全探讨,其有效性及安全性有待进一步确认;而且外泌体的提取及纯化缺乏标准化规模化制备流程等。

Advancing treatment strategies:Insights from network meta-analysis of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

This study examines the pivotal findings of the network meta-analysis of Zhou et al,which evaluated the efficacy of hepatic arterial infusion chemotherapy and combination therapies for advanced hepatocellular carcinoma(HCC).This meta-analysis suggests that therapeutic combinations have greater efficacy than do standard treatments.The article highlights the key insights that have the potential to shift current clinical practice and enhance outcomes for patients with advanced HCC.Additionally,this article discusses further research that can be conducted to optimize these treatments and achieve personalized care for patients with HCC.

Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy

BACKGROUND Owing to the absence of specific symptoms in early-stage gastric cancer,most patients are diagnosed at intermediate or advanced stages.As a result,treatment often shifts from surgery to other therapies,with chemotherapy and targeted therapies being the primary options for advanced gastric cancer treatment.A total of 116 patients with advanced gastric cancer,admitted from January 2021 to December 2023,were selected and divided into two groups of 58 each using the random number table method.The control group received FOLFOX4 chemothe-rapy(oxaliplatin+calcium+folinate+5-fluorouracil)combined with intravenous sindilizumab.The observation group received the same treatment as the control group,supplemented by oral administration of Senqi Shiyiwei granules.Both groups underwent treatment cycles of 3 weeks,with a minimum of two cycles.The therapeutic efficacy,immune mechanisms,and treatment-related toxicity and side effects were compared between the groups.The objective remission rate in the observation group(55.17%)was higher than that of the control group(36.21%)(P<0.05).After two treatment cycle,CD3+,CD4+,and CD4+/CD8+levels were higher in the observation group compared to the control group,while CD8+,regulatory T cells,and natural killer cells were lower(P<0.05).Additionally,the incidence of leukopenia,nausea,and vomiting was lower in observed group(P<0.05).No significant differences were observed in the incidence of other adverse reactions(P>0.05).CONCLUSION Adjuvant therapy with Shenqixian granules may enhance the efficacy of simudizumab combined with FOLFOX4 chemotherapy in advanced gastric cancer and the immune function by increasing immune cell counts,making it a valuable option in clinical treatment.

Call for Paper from Food Science and Human Wellness

Food Science and Human Wellness(FSHW ISSN:2213-4530,CN 10-1750/TS)publishes original research papers demonstrating the latest advancement of multidisci-plinary subjects related to food science and human health.Topics may include but not limited to:nutriology,bio-chemistry,microbiology,immunology and toxicology.

Call for Paper from Food Science and Human Wellness

Food Science and Human Wellness(FSHW ISSN:2213-4530,CN 10-1750/TS)publishes original research papers demonstrating the latest advancement of multidisci-plinary subjects related to food science and human health.Topics may include but not limited to:nutriology,biochemistry,microbiology,immunology and toxicology.

Irreversible electroporation for metastatic pancreatic carcinoma with liver metastasis:What does the evidence say

Irreversible electroporation is a promising non-thermal ablation method that has been shown to increase overall survival in locally advanced pancreatic cancer in some studies.However,higher quality studies with proper controls and randomization are required to establish its superiority when added with neoadjuvant chemotherapy over the current management of choice,which is chemotherapy alone.Further studies are required before establishment of any survival benefit in metastatic pancreatic carcinoma,and such evidence is lacking at present.

Call for Paper from Food Science and Human Wellness

Food Science and Human Wellness (FSHW ISSN:2213-4530,CN 10-1750/TS) publishes original researchpapers demonstrating the latest advancement of multidisci-plinary subjects related to food science and human health.Topics may include but not limited to: nutriology, bio-chemistry, microbiology, immunology and toxicology.Papers regarding components of food especiallynutrients and non-nutrient bioactive compounds (withputative health benefits) are welcomed. FSHW aims tounveil the correlations between food science and humanhealth through the dissemination of both fundamentaland applied research outcomes worldwide.

Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease

Neurotrophic factors as a therapeutic approach in neurodegenerative diseases:A major unmet need in the field of central nervous system diseases is disease-modifying treatments.While for decades there have been various symptomatic treatments available to alleviate the symptoms of the disease,disease-modification,i.e.treatments that stop,significantly delay,or reverse the progression of the disease,has been turned out to a difficult goal to achieve.

Advances in the Development of Gradient Scaffolds Made of Nano‑Micromaterials for Musculoskeletal Tissue Regeneration

The intricate hierarchical structure of musculoskeletal tissues,including bone and interface tissues,necessitates the use of complex scaffold designs and material structures to serve as tissue-engineered substitutes.This has led to growing interest in the development of gradient bone scaffolds with hierarchical structures mimicking the extracellular matrix of native tissues to achieve improved therapeutic outcomes.Building on the anatomical characteristics of bone and interfacial tissues,this review provides a summary of current strategies used to design and fabricate biomimetic gradient scaffolds for repairing musculoskeletal tissues,specifically focusing on methods used to construct compositional and structural gradients within the scaffolds.The latest applications of gradient scaffolds for the regeneration of bone,osteochondral,and tendon-to-bone interfaces are presented.Furthermore,the current progress of testing gradient scaffolds in physiologically relevant animal models of skeletal repair is discussed,as well as the challenges and prospects of moving these scaffolds into clinical application for treating musculoskeletal injuries.

芪桂消癥方加减联合TC化疗治疗晚期卵巢癌的临床研究

目的:探究芪桂消癥方加减联合TC化疗治疗晚期卵巢癌患者的临床疗效。方法:选取2018年10月-2023年4月就诊于黑龙江中医药大学附属第一医院肿瘤科门诊及病房的晚期卵巢癌化疗患者95例,随机分为对照组和观察组,对照组48例,采用TC化疗方案,治疗组47例,采用芪桂消癥方加减联合TC化疗,以21 d为1个周期,共治疗4个周期。观察两组患者血液流变学指标、免疫功能、肿瘤标志物、KPS评分、不良反应发生率等。结果:治疗后,治疗组血液流变学指标纤维蛋白原、全血黏度高切、全血黏度低切水平均低于对照组(P<0.05);CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)水平高于对照组(P<0.05),CD8^(+)水平低于对照组(P<0.05);CA125、CA199、HE4水平低于对照组(P<0.05);KPS评分高于对照组(P<0.05);不良反应发生率低于对照组(P<0.05)。结论:芪桂消癥方加减联合TC化疗治疗方案在改善晚期卵巢癌患者血液流变学指标、免疫功能、肿瘤标志物水平、生活质量等方面具有更好的临床疗效,且能够降低不良反应发生率。

Late effects of the treatment of childhood cancer

Excellent progress has been made in the last few decades in the cure rates of pediatric malignancies,with more than 80%of children with cancer who have access to contemporary treatment being cured.However,the therapies responsible for this survival can also produce adverse physical and psychological long-term outcomes,referred to as late effects,which appear months to years after the completion of cancer treatment.Research has shown that 60%to 90%of childhood cancer survivors(CCSs)develop one or more chronic health conditions,and 20%to 80%of survivors experience severe or life-threatening complications during adulthood.Therefore,understanding the late side effects of such treatments is important to improve the health and quality of life of the growing population of CCSs.

Influence of introducing Zr,Ti,Nb and Ce elements on externally solidified crystals and mechanical properties of high-pressure die-casting Al–Si alloy

High pressure die casting(HPDC)AlSi10Mn Mg alloy castings are widely used in the automobile industry.Mg can optimize the mechanical properties of castings through heat treatment,while the release of thermal stress arouses the deformation of large integrated die-castings.Herein,the development of non-heat treatment Al alloys is becoming the hot topic.In addition,HPDC contains externally solidified crystals(ESCs),which are detrimental to the mechanical properties of castings.To achieve high strength and toughness of non-heat treatment die-casting Al-Si alloy,we used AlSi9Mn alloy as matrix with the introduction of Zr,Ti,Nb,and Ce.Their influences on ESCs and mechanical properties were systematically investigated through three-dimensional reconstruction and thermodynamic simulation.Our results reveal that the addition of Ti increased ESCs'size and porosity,while the introduction of Nb refined ESCs and decreased porosity.Meanwhile,large-sized Al_3(Zr,Ti)phases formed and degraded the mechanical properties.Subsequent introduction of Ce resulted in the poisoning effect and reduced mechanical properties.

Intersection of two rare conditions:Clinical reflection on tuberous sclerosis combined with primary lymphedema

This editorial discusses a case report recently published in the World Journal of Clinical Cases.The report describes the clinical presentation,imaging,diagnosis,and treatment of a patient with tuberous sclerosis complex(TSC)combined with primary lymphedema(PLE).Additionally,it retrospectively analyzes the data of 16 previously reported cases of children with TSC combined with PLE to summarize the epidemiology,genetic diagnosis,and current main treatments of these patients.The report also speculates on the pathological and physiological mechanisms underlying TSC combined with PLE.TSC combined with PLE is rare;therefore,the report provides a theoretical basis for understanding the pathophysiological mechanisms and treatment options for patients with TSC and PLE.Comprehensive clinical management of TSC is essential due to the diverse and multiorgan nature of its manifestations,often requiring a multidisciplinary approach for newly diagnosed cases.